Published on in Vol 8, No 11 (2022): November
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/38898, first published
.
![The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data](https://asset.jmir.pub/assets/5cd4fe69e03f377becc60514c5478663.png 480w,https://asset.jmir.pub/assets/5cd4fe69e03f377becc60514c5478663.png 960w,https://asset.jmir.pub/assets/5cd4fe69e03f377becc60514c5478663.png 1920w,https://asset.jmir.pub/assets/5cd4fe69e03f377becc60514c5478663.png 2500w)
There are currently no tweets available for this article within the specified range.